Inria and InSilicoTrials partner up on a European project leveraging simulation for cardiac devices and drugs
Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is
